Loading...

Categories

20 Vietnam Pharmaceuticals Reports

Vietnam Diabetes Care Drugs Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, NovoNordisk

Asia - Pacific Human Insulin Market

Country Covered: Vietnam

Study Period: 2018- 2028

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee

Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb

Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: AstraZeneca, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Biocon Ltd.

Asia-Pacific Diabetes Care Drugs Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis

Asia-Pacific Sodium-dependent Glucose Cotransporter 2 (SGLT-2) Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb

APAC Biguanide Market

Country Covered: Vietnam

Study Period: 2018- 2028

Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis

Asia-Pacific Oral Anti-Diabetic Drug Market

Country Covered: Vietnam

Study Period: 2018-2028

Major Players: Sanofi, Eli Lily, Astellas, Astrazeneca, Janssen

Insulin Market

Country Covered: Vietnam

Study Period: 2018 - 2028

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Diabetes Drug Market

Country Covered: Vietnam

Study Period: 2018 - 2028

Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company

Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company

Oral Anti-Diabetic Drugs Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca

Alpha-glucosidase Inhibitors Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.

Biguanides Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Combination Anti-Diabetes Drugs Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S

Meglitinide Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Country Covered: Vietnam

Study Period: 2018- 2028

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin Market

Country Covered: Vietnam

Study Period: 2018- 2028

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Insulin Glargine Market

Country Covered: Vietnam

Study Period: 2017- 2028

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar